Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
53
CHRW Quote, Financials, Valuation and Earnings
Last price:
$104.28
Seasonality move
:
2.77%
Day range:
$102.96 - $105.40
52-week range:
$65.00 - $114.82
Dividend yield:
2.36%
P/E ratio:
36.10x
P/S ratio:
0.71x
P/B ratio:
7.52x
Volume:
1.9M
Avg. volume:
1.2M
1-year change:
22.41%
Market cap:
$12.3B
Revenue:
$17.6B
EPS (TTM):
$2.89
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.3B | $16.2B | $23.1B | $24.7B | $17.6B | |
| Revenue Growth (YoY) | -7.95% | 5.86% | 42.54% | 6.9% | -28.75% | |
| Cost of Revenues | $14B | $15B | $21.5B | $22.8B | $16.5B | |
| Gross Profit | $1.3B | $1.2B | $1.6B | $1.9B | $1.1B | |
| Gross Profit Margin | 8.41% | 7.22% | 6.96% | 7.57% | 6.47% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $497.8M | $496.1M | $526.4M | $603.4M | $624.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $497.8M | $496.1M | $526.4M | $603.4M | $624.3M | |
| Operating Income | $790M | $673.3M | $1.1B | $1.3B | $514.6M | |
| Net Interest Expenses | $47.7M | $44.9M | $59.8M | $100M | $105.4M | |
| EBT. Incl. Unusual Items | $742.3M | $628.3M | $1B | $1.2B | $409.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $165.3M | $121.9M | $178M | $226.2M | $84.1M | |
| Net Income to Company | $577M | $506.4M | $844.2M | $940.5M | $325.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $577M | $506.4M | $844.2M | $940.5M | $325.1M | |
| Basic EPS (Cont. Ops) | $4.21 | $3.74 | $6.37 | $7.48 | $2.74 | |
| Diluted EPS (Cont. Ops) | $4.19 | $3.72 | $6.31 | $7.40 | $2.72 | |
| Weighted Average Basic Share | $137M | $135.5M | $132.5M | $125.7M | $118.6M | |
| Weighted Average Diluted Share | $137.7M | $136.2M | $133.8M | $127.2M | $119.7M | |
| EBITDA | $890.4M | $775M | $1.2B | $1.4B | $613.6M | |
| EBIT | $790M | $673.3M | $1.1B | $1.3B | $514.6M | |
| Revenue (Reported) | $15.3B | $16.2B | $23.1B | $24.7B | $17.6B | |
| Operating Income (Reported) | $790M | $673.3M | $1.1B | $1.3B | $514.6M | |
| Operating Income (Adjusted) | $790M | $673.3M | $1.1B | $1.3B | $514.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $6.3B | $6B | $4.3B | $4.6B | |
| Revenue Growth (YoY) | 9.56% | 48.26% | -3.96% | -27.83% | 6.99% | |
| Cost of Revenues | $3.9B | $5.8B | $5.6B | $4B | $4.3B | |
| Gross Profit | $286.4M | $444.3M | $449.6M | $291.3M | $373.7M | |
| Gross Profit Margin | 6.78% | 7.09% | 7.48% | 6.71% | 8.05% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $118.1M | $133.5M | $162M | $177.8M | $193.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $118.1M | $133.5M | $162M | $177.8M | $193.6M | |
| Operating Income | $168.2M | $310.8M | $287.6M | $113.5M | $180.1M | |
| Net Interest Expenses | $7.5M | $16.7M | $16M | $20.7M | $36.3M | |
| EBT. Incl. Unusual Items | $160.8M | $294.1M | $271.6M | $92.8M | $143.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $24.2M | $47.1M | $45.8M | $10.8M | $46.6M | |
| Net Income to Company | $136.5M | $247.1M | $225.8M | $81.9M | $97.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $136.5M | $247.1M | $225.8M | $81.9M | $97.2M | |
| Basic EPS (Cont. Ops) | $1.01 | $1.87 | $1.81 | $0.69 | $0.81 | |
| Diluted EPS (Cont. Ops) | $1.00 | $1.85 | $1.78 | $0.68 | $0.80 | |
| Weighted Average Basic Share | $135.7M | $131.8M | $125M | $118.5M | $119.9M | |
| Weighted Average Diluted Share | $137.1M | $133.4M | $127.2M | $119.8M | $121.2M | |
| EBITDA | $195.2M | $333.2M | $310.6M | $139.1M | $204.1M | |
| EBIT | $168.2M | $310.8M | $287.6M | $113.5M | $180.1M | |
| Revenue (Reported) | $4.2B | $6.3B | $6B | $4.3B | $4.6B | |
| Operating Income (Reported) | $168.2M | $310.8M | $287.6M | $113.5M | $180.1M | |
| Operating Income (Adjusted) | $168.2M | $310.8M | $287.6M | $113.5M | $180.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $15.5B | $21.1B | $26.1B | $18.4B | $17.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $14.3B | $19.6B | $24.2B | $17.2B | $16.5B | |
| Gross Profit | $1.1B | $1.5B | $2B | $1.2B | $1.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $514.7M | $501.9M | $575.5M | $651.7M | $642.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $514.7M | $501.9M | $575.5M | $651.7M | $642.6M | |
| Operating Income | $603.3M | $1B | $1.4B | $571.2M | $592.8M | |
| Net Interest Expenses | $43.7M | $53.5M | $75.9M | $109.7M | $112.7M | |
| EBT. Incl. Unusual Items | $559.6M | $948.1M | $1.3B | $461.5M | $480M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $101.9M | $186.1M | $239.8M | $71.1M | $132.7M | |
| Net Income to Company | $457.7M | $762M | $1.1B | $390.3M | $347.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $457.7M | $762M | $1.1B | $390.3M | $347.4M | |
| Basic EPS (Cont. Ops) | $3.39 | $5.70 | $8.36 | $3.29 | $2.91 | |
| Diluted EPS (Cont. Ops) | $3.36 | $5.65 | $8.24 | $3.25 | $2.89 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $705.7M | $1.1B | $1.5B | $671.2M | $688.7M | |
| EBIT | $603.3M | $1B | $1.4B | $571.2M | $592.8M | |
| Revenue (Reported) | $15.5B | $21.1B | $26.1B | $18.4B | $17.8B | |
| Operating Income (Reported) | $603.3M | $1B | $1.4B | $571.2M | $592.8M | |
| Operating Income (Adjusted) | $603.3M | $1B | $1.4B | $571.2M | $592.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $11.7B | $16.6B | $19.6B | $13.4B | $13.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.8B | $15.4B | $18.1B | $12.5B | $12.6B | |
| Gross Profit | $838.1M | $1.2B | $1.5B | $882.1M | $978.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $371.6M | $377.4M | $426.6M | $474.9M | $493.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $371.6M | $377.4M | $426.6M | $474.9M | $493.2M | |
| Operating Income | $466.5M | $794.7M | $1.1B | $407.2M | $485.3M | |
| Net Interest Expenses | $32.9M | $41.4M | $57.5M | $67.3M | $74.6M | |
| EBT. Incl. Unusual Items | $433.6M | $753.3M | $1B | $339.9M | $410.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $74.9M | $139.1M | $200.9M | $45.8M | $94.4M | |
| Net Income to Company | $358.6M | $614.1M | $844.3M | $294.2M | $316.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $358.6M | $614.1M | $844.3M | $294.2M | $316.4M | |
| Basic EPS (Cont. Ops) | $2.66 | $4.61 | $6.59 | $2.48 | $2.65 | |
| Diluted EPS (Cont. Ops) | $2.63 | $4.57 | $6.50 | $2.45 | $2.63 | |
| Weighted Average Basic Share | $406.2M | $399.6M | $383.9M | $355.6M | $358.6M | |
| Weighted Average Diluted Share | $408.7M | $404M | $389.7M | $359.5M | $360.7M | |
| EBITDA | $543.5M | $863.3M | $1.2B | $483.1M | $558.2M | |
| EBIT | $466.5M | $794.7M | $1.1B | $407.2M | $485.3M | |
| Revenue (Reported) | $11.7B | $16.6B | $19.6B | $13.4B | $13.5B | |
| Operating Income (Reported) | $466.5M | $794.7M | $1.1B | $407.2M | $485.3M | |
| Operating Income (Adjusted) | $466.5M | $794.7M | $1.1B | $407.2M | $485.3M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $447.9M | $243.8M | $257.4M | $217.5M | $145.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2B | $2.4B | $4B | $3B | $2.4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $85M | $51.2M | $129.6M | $122.4M | $163.3M | |
| Total Current Assets | $2.6B | $2.9B | $4.8B | $3.6B | $2.9B | |
| Property Plant And Equipment | $519.3M | $498.7M | $432.4M | $531.6M | $498.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.3B | $1.5B | $1.5B | $1.5B | $1.5B | |
| Other Intangibles | $142.7M | $173.5M | $159.7M | $152.8M | $146.2M | |
| Other Long-Term Assets | $33.7M | $24.5M | -- | -- | -- | |
| Total Assets | $4.6B | $5.1B | $7B | $6B | $5.2B | |
| Accounts Payable | $984.6M | $1.2B | $1.8B | $1.5B | $1.3B | |
| Accrued Expenses | $163.9M | $308M | $514M | $367.1M | $307.4M | |
| Current Portion Of Long-Term Debt | $142.9M | -- | $525M | $1.1B | $160M | |
| Current Portion Of Capital Lease Obligations | $61.3M | $66.2M | $66.3M | $73.7M | $74.5M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.6B | $1.8B | $3.3B | $3.3B | $2.1B | |
| Long-Term Debt | $1.1B | $1.1B | $1.4B | $920M | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3B | $3.3B | $5B | $4.6B | $3.8B | |
| Common Stock | $13.5M | $13.4M | $12.9M | $11.6M | $11.7M | |
| Other Common Equity Adj | -$76.1M | -$46M | -$61.1M | -$88.9M | -$80.9M | |
| Common Equity | $1.7B | $1.9B | $2B | $1.4B | $1.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.7B | $1.9B | $2B | $1.4B | $1.4B | |
| Total Liabilities and Equity | $4.6B | $5.1B | $7B | $6B | $5.2B | |
| Cash and Short Terms | $447.9M | $243.8M | $257.4M | $217.5M | $145.5M | |
| Total Debt | $1.2B | $1.1B | $1.9B | $2B | $1.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $252.6M | $202.6M | $187.5M | $174.7M | $131.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.3B | $3.7B | $3.8B | $2.4B | $2.6B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $65.8M | $89.5M | $80M | $137.5M | $137.9M | |
| Total Current Assets | $2.9B | $4.4B | $4.4B | $3B | $3.3B | |
| Property Plant And Equipment | $523.1M | $474.7M | $508.1M | $501.8M | $466.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.5B | $1.5B | $1.5B | $1.5B | $1.4B | |
| Other Intangibles | $118.7M | $96M | $68.1M | $46.6M | $31M | |
| Other Long-Term Assets | $90.3M | $88.8M | $120.2M | $130.2M | $109.4M | |
| Total Assets | $5.1B | $6.6B | $6.8B | $5.3B | $5.6B | |
| Accounts Payable | $1.2B | $1.8B | $1.7B | $1.4B | $1.3B | |
| Accrued Expenses | $222.4M | $476.4M | $485.5M | $327.2M | $374.5M | |
| Current Portion Of Long-Term Debt | $60M | $632M | $779M | $663M | $150M | |
| Current Portion Of Capital Lease Obligations | $66.7M | $66.5M | $71M | $73.7M | $74.5M | |
| Other Current Liabilities | -- | -- | -- | -- | $96.7M | |
| Total Current Liabilities | $1.8B | $3.3B | $3.4B | $2.6B | $2.2B | |
| Long-Term Debt | $1.1B | $1.1B | $1.4B | $920.7M | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $4.7B | $5.1B | $3.9B | $4B | |
| Common Stock | $13.6M | $13M | $12.1M | $11.6M | $11.8M | |
| Other Common Equity Adj | -$70.9M | -$65.5M | -$137.7M | -$107.8M | -$72.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.9B | $2B | $1.7B | $1.4B | $1.6B | |
| Total Liabilities and Equity | $5.1B | $6.6B | $6.8B | $5.3B | $5.6B | |
| Cash and Short Terms | $252.6M | $202.6M | $187.5M | $174.7M | $131.7M | |
| Total Debt | $1.2B | $1.7B | $2.2B | $1.6B | $1.6B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $577M | $506.4M | $844.2M | $940.5M | $325.1M | |
| Depreciation & Amoritzation | $100.4M | $101.7M | $91.3M | $92.8M | $99M | |
| Stock-Based Compensation | $39.1M | $44M | $130M | $90.7M | $58.2M | |
| Change in Accounts Receivable | $235.1M | -$517.6M | -$1.8B | $1.1B | $675.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $835.4M | $499.2M | $95M | $1.7B | $731.9M | |
| Capital Expenditures | $70.5M | $54M | $70.9M | $128.5M | $84.1M | |
| Cash Acquisitions | -$59.2M | -$223.2M | -$14.8M | -- | -- | |
| Cash From Investing | -$113M | -$271.7M | -$85.7M | -$64.9M | -$82.8M | |
| Dividends Paid (Ex Special Dividend) | -$277.8M | -$210M | -$277.3M | -$285.3M | -$291.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $1.4B | $4B | $4.7B | $3.9B | |
| Long-Term Debt Repaid | -$1.6B | -$1.6B | -$3.2B | -$4.6B | -$4.3B | |
| Repurchase of Common Stock | -$309.4M | -$177.5M | -$581.8M | -$1.5B | -$63.9M | |
| Other Financing Activities | -$15.1M | -$17.9M | -$26.7M | -$28.4M | -$25.3M | |
| Cash From Financing | -$651.3M | -$440.7M | $7.6M | -$1.6B | -$717.8M | |
| Beginning Cash (CF) | $378.6M | $447.9M | $243.8M | $257.4M | $217.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $71.1M | -$213.2M | $16.9M | -$34.3M | -$68.7M | |
| Ending Cash (CF) | $447.9M | $243.8M | $257.4M | $217.5M | $145.5M | |
| Levered Free Cash Flow | $765M | $445.2M | $24M | $1.5B | $647.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $136.5M | $247.1M | $225.8M | $81.9M | $97.2M | |
| Depreciation & Amoritzation | $26.9M | $22.4M | $23M | $25.5M | $23.9M | |
| Stock-Based Compensation | $10.8M | $40.8M | $25.8M | $15.7M | $22M | |
| Change in Accounts Receivable | -$352.3M | -$697.9M | $601M | $7.7M | -$125.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$168.6M | -$73.5M | $625.5M | $205.2M | $108.1M | |
| Capital Expenditures | $15.2M | $22.7M | $31.3M | $16.7M | $17.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.2M | -$22.7M | -$31.3M | -$15.4M | -$17.3M | |
| Dividends Paid (Ex Special Dividend) | -$70.3M | -$69.2M | -$71M | -$72.7M | -$73M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $64M | $1.1B | $939M | $917M | $808.5M | |
| Long-Term Debt Repaid | -$4M | -$748.3M | -$1B | -$1.1B | -$856.5M | |
| Repurchase of Common Stock | -- | -$165.9M | -$532.9M | -$1.1M | -- | |
| Other Financing Activities | -$1.6M | -$2.2M | -$2.8M | -$1.9M | -$4.1M | |
| Cash From Financing | $68.4M | $128M | -$636.8M | -$219.4M | -$64.2M | |
| Beginning Cash (CF) | $362.2M | $172.8M | $238.9M | $210.2M | $113.2M | |
| Foreign Exchange Rate Adjustment | $5.8M | -$1.9M | -$8.8M | -$3.4M | $2.9M | |
| Additions / Reductions | -$115.5M | $31.8M | -$42.6M | -$29.5M | $26.6M | |
| Ending Cash (CF) | $252.6M | $202.6M | $187.5M | $174.7M | $131.7M | |
| Levered Free Cash Flow | -$183.8M | -$96.2M | $594.2M | $188.6M | $90.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $457.7M | $762M | $1.1B | $390.3M | $347.4M | |
| Depreciation & Amoritzation | $102.4M | $93.3M | $91.4M | $100M | $96M | |
| Stock-Based Compensation | $31.6M | $104.8M | $114.4M | $49.6M | $85.1M | |
| Change in Accounts Receivable | -$301.8M | -$1.6B | -$136.9M | $1.5B | -$389.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $548.6M | $181.2M | $952.6M | $1.5B | $288.5M | |
| Capital Expenditures | $59.8M | $66.3M | $119M | $95.8M | $75.2M | |
| Cash Acquisitions | -$223.2M | -$14.7M | -$1K | -- | -- | |
| Cash From Investing | -$277.5M | -$81.1M | -$55.8M | -$94.1M | -$75.2M | |
| Dividends Paid (Ex Special Dividend) | -$277.3M | -$211.5M | -$284.7M | -$288M | -$292.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.6B | $3.2B | $5.1B | $3.6B | $3.6B | |
| Long-Term Debt Repaid | -$1.7B | -$2.6B | -$4.7B | -$4.2B | -$3.6B | |
| Repurchase of Common Stock | -$136.7M | -$537.8M | -$1.2B | -$500.2M | -- | |
| Other Financing Activities | -$17.3M | -$26.6M | -$28.1M | -$25.5M | -$25.4M | |
| Cash From Financing | -$409.2M | -$155.8M | -$896.4M | -$1.4B | -$250.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$138M | -$55.6M | $484K | -$13.2M | -$37.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $488.8M | $114.9M | $833.6M | $1.4B | $213.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $358.6M | $614.1M | $844.3M | $294.2M | $316.4M | |
| Depreciation & Amoritzation | $77.1M | $68.6M | $68.7M | $75.9M | $72.9M | |
| Stock-Based Compensation | $33.1M | $94M | $78.3M | $37.3M | $64.2M | |
| Change in Accounts Receivable | -$423.7M | -$1.5B | $157M | $578.6M | -$486.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $337M | $19.1M | $876.8M | $684.6M | $241.2M | |
| Capital Expenditures | $40.3M | $52.6M | $100.7M | $68M | $59.1M | |
| Cash Acquisitions | -$223.2M | -$14.7M | -- | -- | -- | |
| Cash From Investing | -$258M | -$67.3M | -$37.4M | -$66.7M | -$59.1M | |
| Dividends Paid (Ex Special Dividend) | -$207.4M | -$208.9M | -$216.3M | -$218.9M | -$220.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1B | $2.8B | $3.9B | $2.8B | $2.5B | |
| Long-Term Debt Repaid | -$1.1B | -$2.1B | -$3.6B | -$3.2B | -$2.5B | |
| Repurchase of Common Stock | -$68.6M | -$428.8M | -$1B | -$63.9M | -- | |
| Other Financing Activities | -$16.5M | -$25.2M | -$26.6M | -$23.8M | -$23.9M | |
| Cash From Financing | -$275M | $9.9M | -$894M | -$651.5M | -$184.2M | |
| Beginning Cash (CF) | $1.1B | $634.2M | $739.1M | $666.8M | $380.5M | |
| Foreign Exchange Rate Adjustment | $612K | -$2.8M | -$15.2M | -$6.7M | -$653K | |
| Additions / Reductions | -$195.9M | -$38.3M | -$54.7M | -$33.6M | -$2.2M | |
| Ending Cash (CF) | $909.4M | $593.1M | $669.3M | $624M | $366.7M | |
| Levered Free Cash Flow | $296.8M | -$33.5M | $776.1M | $616.6M | $182.1M | |
Get CHRW Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CHRW
Sector
P/E ratio
36.10x
17.94x
PEG ratio
--
0.34x
P/B ratio
7.52x
1.76x
Price / LTM sales
0.71x
0.97x
Growth Metrics
CHRW
Sector
Revenue growth
6.99%
1.77%
Earnings growth
17.65%
1.67%
Revenue (5-year growth)
1.14%
4.31%
Earnings forecast
$1.15
$0.46
Profitability
CHRW
Sector
Profitability FY 2023
$1.1B
$434.2M
Return on invested capital
11.25%
5.93%
Return on assets
6.4%
3.69%
Return on equity
23.46%
8.87%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Jan
31
Estimated Next Earnings Date
Jan
29
Balance Sheet
CHRW
Sector
Total cash
$131.7M
$170.4M
Short term investments
--
$46.5M
Total assets
$5.2B
$2.1B
Long term debt
$1.6B
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
